Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival

The number of long-term survivors of high-risk neuroblastoma remains discouraging, with 10-year survival as low as 20%, despite decades of considerable international efforts to improve outcome. Major obstacles remain and include managing resistance to induction therapy, which causes tumor progressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Thole, Theresa M, Lodrini, Marco, Fabian, Johannes, Wuenschel, Jasmin, Pfeil, Sebastian, Hielscher, Thomas, Kopp-Schneider, Annette, Heinicke, Ulrike, Fulda, Simone, Witt, Olaf, Eggert, Angelika, Fischer, Matthias, Deubzer, Hedwig E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386552/
https://www.ncbi.nlm.nih.gov/pubmed/28252645
http://dx.doi.org/10.1038/cddis.2017.49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386552/
https://www.ncbi.nlm.nih.gov/pubmed/28252645
http://dx.doi.org/10.1038/cddis.2017.49

Ejemplares similares